CW
VRTX icon

Channel Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Channel Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Sell
424
-6,164
-94% -$2.73M 0.05% 178
2026
Q1 		$2.94M Sell
6,588
-18
-0.3% -$8.39K 0.71% 51
2025
Q4 		$2.99M Sell
6,606
-3,953
-37% -$1.7M 0.76% 45
2025
Q3 		$4.14M Sell
10,559
-3,318
-24% -$1.39M 1.11% 31
2025
Q2 		$6.18M Buy
13,877
+11,833
+579% +$5.45M 1.75% 17
2025
Q1 		$991K Buy
2,044
+266
+15% +$124K 0.31% 66
2024
Q4 		$716K Buy
+1,778
New +$824K 0.23% 80

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Channel Wealth's VRTX Position: Q2 2026 in Review

Channel Wealth reduced its Vertex Pharmaceuticals (VRTX) stake by 94% in Q2 2026, selling an estimated $2.73M and leaving 424 shares worth $211K. The position accounts for 0.05% of the portfolio, ranked #178.

Channel Wealth first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.18M in Q2 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Channel Wealth held 424 shares of Vertex Pharmaceuticals worth $211K as of Q2 2026.
  • Channel Wealth sold 6,164 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.73M.
  • Vertex Pharmaceuticals made up 0.05% of Channel Wealth's portfolio in Q2 2026, its #178 holding.
  • Channel Wealth first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Channel Wealth's Vertex Pharmaceuticals position peaked at $6.18M in Q2 2025.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Channel Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.